Explore Business Standard
Don’t miss the latest developments in business and finance.
Dabur India
Home-grown FMCG major Dabur has lowered the time of its strategic vision cycle from four years to three years aiming to create a more agile organisation amid a slowdown in the FMCG space and volatile geopolitical landscape. It has engaged consulting firm McKinsey & Co to refine and align its strategies for the next three years in line with the evolving dynamics, its CEO Mohit Malhotra said in an earnings call. "This exercise has already begun, and we plan to conclude the same by the end of the fiscal year. This will enable us to capture emerging opportunities and navigate the future with sharper and more focused vision," he said. Dabur has four-year vision plans and is currently in the seventh vision cycle. "Earlier we used to have a four-year vision cycle... We feel that in this volatile and heavy-headwind macroeconomic environment and FMCG not doing so well as a sector... we require a validation of our strategies through an external consultant," he said. Malhorta further said ..
FMCG major Dabur has become the second-largest player in the oral care segment in the modern trade channels, its chief executive officer Mohit Malhotra claimed on Monday. The company, which operates in the segment with Dabur Red Toothpaste and premium brand Meswak, ended the quarter with a 9.1 per cent growth and it believes that this segment has " huge potential". "The Gel toothpaste portfolio has received a good response, recording 50%+ y-o-y growth this quarter. Dabur oral care is now the 2nd brand in Modern Trade Pan-India," he said in the post-earnings call. "Even in modern trade, where the competitor is very strong with premium variants etc., there also we have become a number two brand now in modern trade. So, this is very encouraging for us," Malhotra added. The oral care market is led by Colgate Palmolive and FMCG major HUL is at the second spot with brands such as Pepsodent, Closeup and Ayush. "Dabur Red is doing well on the back of tailwind coming from the herbal catego
Homegrown FMCG major Dabur India Ltd on Thursday reported a 1.85 per cent increase in consolidated net profit to Rs 515.82 crore in the December quarter. The company had posted a net profit of Rs 506.44 crore in the year-ago period, Dabur India said in a regulatory filing. Its revenue from operations was up 3 per cent to Rs 3,355.25 crore during the quarter under review. It was Rs 3,255.06 crore in the corresponding quarter of the previous fiscal year. Dabur India's total expenses were at Rs 2,826.20 crore, up 3.9 per cent in the December quarter. Total income of Dabur, which includes other income, was at Rs 3,483.28 crore, up 3 per cent. Shares of Dabur India Ltd were trading at Rs 535.10 on the BSE after lunch session, up 3.27 per cent from the previous close.
Hit by inflation, higher input costs and pricing measures, fast-moving consumer goods companies are expected to see a contraction in their gross margin and a modest-to-flat operating profit in the October-December quarter. Several FMCG makers are likely to log a low single-digit rise in their revenue, returning to the cycle of value-driven growth. One of the reasons could be that a number of companies have opted for a price hike in the December quarter due to rising costs of input items such as copra, vegetable oil, and palm oil. The price hikes came at a time when the urban market was dragged down by lowered consumption due to high food inflation. However, the rural market, which is slightly above one-third of the total FMCG market, stayed ahead of it. Some of the listed FMCG companies, such as Dabur and Marico, shared their updates for the third quarter of FY25, and analysts expect either flat or low single-digit volume growth. Home-grown firm Dabur expects a "low single-digit .